TGFβ or WNT/β-catenin-induced epithelial-mesenchymal transition (EMT) and tumor resistance may be linked to CLDN10, which offers promise as a prognostic biomarker in ovarian cancer (Gao et al., 2017; Li et al., 2020b). This evidence concerns the gene TGFB1 and ovarian carcinoma.